<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35596571</PMID><DateCompleted><Year>2022</Year><Month>05</Month><Day>24</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2047-2986</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><PubDate><Year>2022</Year><Month>May</Month><Day>21</Day></PubDate></JournalIssue><Title>Journal of global health</Title><ISOAbbreviation>J Glob Health</ISOAbbreviation></Journal><ArticleTitle>Symptoms and signs of long COVID: A rapid review and meta-analysis.</ArticleTitle><Pagination><StartPage>05014</StartPage><MedlinePgn>05014</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">05014</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7189/jogh.12.05014</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Long COVID is defined as symptoms and signs related to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that are present at least four weeks following acute infection. These symptoms and signs are poorly characterised but may be associated with significant morbidity. We sought to synthesise the evidence on their incidence to guide future research, policy and practice.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">We searched Medline and Embase for longitudinal cohort studies from January 2020 to July 2021 that investigated adults with long COVID at least four weeks after acute infection. Risk of bias was assessed using the Joanna Briggs Institute checklist for cohort studies. Random-effects meta-analyses were performed with subgroup analysis by follow-up time (4-12 vs more than 12 weeks).</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">19 studies were included, 13 of which included patients hospitalised with COVID-19. The total sample size was 10&#x2009;643 and the follow-up time ranged from 30 to 340 days. Risk of bias was assessed as high in one study, moderate in two studies and low in the remaining 16 studies. The most common symptoms and signs seen at any time point in long COVID were fatigue (37%; 95% confidence interval (CI)&#x2009;=&#x2009;23-55), dyspnoea (21%; 95% CI&#x2009;=&#x2009;14-30), olfactory dysfunction (17%; 95% CI&#x2009;=&#x2009;9-29), myalgia (12%; 95% CI&#x2009;=&#x2009;5-25), cough (11%; 95% CI&#x2009;=&#x2009;6-20) and gustatory dysfunction (10%; 95% CI&#x2009;=&#x2009;7-17). High heterogeneity was seen for all meta-analyses and the presence of some funnel plot asymmetry may indicate reporting bias. No effect of follow-up time was found for any symptom or sign included in the subgroup analysis.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">We have summarised evidence from longitudinal cohort studies on the most common symptoms and signs associated with long COVID. High heterogeneity seen in the meta-analysis means pooled incidence estimates should be interpreted with caution. This heterogeneity may be attributable to studies including patients from different health care settings and countries.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 by the Journal of Global Health. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Healey</LastName><ForeName>Quin</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Edinburgh Medical School, The University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sheikh</LastName><ForeName>Aziz</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Usher Institute, The University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daines</LastName><ForeName>Luke</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Usher Institute, The University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vasileiou</LastName><ForeName>Eleftheria</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Usher Institute, The University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>COV/LTE/20/15</GrantID><Acronym>CSO_</Acronym><Agency>Chief Scientist Office</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>05</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Scotland</Country><MedlineTA>J Glob Health</MedlineTA><NlmUniqueID>101578780</NlmUniqueID><ISSNLinking>2047-2978</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Competing Interests: The authors completed the ICMJE Unified Competing Interest Form (available upon request from the corresponding author) and declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>5</Month><Day>21</Day><Hour>2</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>5</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>5</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>5</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35596571</ArticleId><ArticleId IdType="pmc">PMC9125197</ArticleId><ArticleId IdType="doi">10.7189/jogh.12.05014</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>National Institute for Health and Care Excellence. COVID-19 rapid guideline: managing the long-term effects of COVID-19 (NICE guideline 188). 2021. Available: https://www.nice.org.uk/guidance/ng188. Accessed: 24 January 2022.</Citation></Reference><Reference><Citation>Kingstone T, Taylor AK, O'Donnell CA, Atherton H, Blane DN, Chew-Graham CA.Finding the 'right' GP: a qualitative study of the experiences of people with long-COVID. BJGP Open. 2020;4:bjgpopen20X101143. 10.3399/bjgpopen20X101143</Citation><ArticleIdList><ArticleId IdType="doi">10.3399/bjgpopen20X101143</ArticleId><ArticleId IdType="pmc">PMC7880173</ArticleId><ArticleId IdType="pubmed">33051223</ArticleId></ArticleIdList></Reference><Reference><Citation>Cucinotta D, Vanelli M.WHO declares COVID-19 a pandemic. Acta Biomed. 2020;91:157.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7569573</ArticleId><ArticleId IdType="pubmed">32191675</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organisation. COVID-19 Dashboard. Available: https://covid19.who.int/. Accessed: 24 January 2022.</Citation></Reference><Reference><Citation>Glasper A.How the UK plans to tackle long COVID. Br J Healthc Assist. 2021;15:402-6. 10.12968/bjha.2021.15.8.402</Citation><ArticleIdList><ArticleId IdType="doi">10.12968/bjha.2021.15.8.402</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabrera Martimbianco AL, Pacheco RL, Bagattini AM, Riera R.Frequency, signs and symptoms, and criteria adopted for long COVID-19: A systematic review. Int J Clin Pract. 2021;75:e14357. 10.1111/ijcp.14357</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijcp.14357</ArticleId><ArticleId IdType="pmc">PMC8236920</ArticleId><ArticleId IdType="pubmed">33977626</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelen M, Manoharan L, Elkheir N, Cheng V, Dagens A, Hastie C, et al. Characterising long COVID: a living systematic review. BMJ Glob Health. 2021;6:e005427. 10.1136/bmjgh-2021-005427</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2021-005427</ArticleId><ArticleId IdType="pmc">PMC8478580</ArticleId><ArticleId IdType="pubmed">34580069</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. 2021;11:16144. 10.1038/s41598-021-95565-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4:1-9. 10.1186/2046-4053-4-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2046-4053-4-1</ArticleId><ArticleId IdType="pmc">PMC4320440</ArticleId><ArticleId IdType="pubmed">25554246</ArticleId></ArticleIdList></Reference><Reference><Citation>Garritty C, Gartlehner G, Nussbaumer-Streit B, King VJ, Hamel C, Kamel C, et al. Cochrane Rapid Reviews Methods Group offers evidence-informed guidance to conduct rapid reviews. J Clin Epidemiol. 2021;130:13-22. 10.1016/j.jclinepi.2020.10.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2020.10.007</ArticleId><ArticleId IdType="pmc">PMC7557165</ArticleId><ArticleId IdType="pubmed">33068715</ArticleId></ArticleIdList></Reference><Reference><Citation>Moola S, Munn Z, Tufanaru C, Aromataris E, Sears K, Sfetcu R, et al. Chapter 7: Systematic reviews of etiology and risk. Joanna Briggs Institute Reviewer's Manual The Joanna Briggs Institute. 2017;5.</Citation></Reference><Reference><Citation>Barsky AJ.Forgetting, fabricating, and telescoping: the instability of the medical history. Arch Intern Med. 2002;162:981-4. 10.1001/archinte.162.9.981</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.162.9.981</ArticleId><ArticleId IdType="pubmed">11996606</ArticleId></ArticleIdList></Reference><Reference><Citation>Amorim Dos Santos J, Normando A, Carvalho da Silva R, Acevedo A, De Luca Canto G, Sugaya N, et al. Oral manifestations in patients with COVID-19: a living systematic review. J Dent Res. 2021;100:141-54. 10.1177/0022034520957289</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0022034520957289</ArticleId><ArticleId IdType="pubmed">32914677</ArticleId></ArticleIdList></Reference><Reference><Citation>de Lima F, Melo G, Fernandes DA, Santos GM, Neto FR.Effects of total knee arthroplasty for primary knee osteoarthritis on postural balance: A systematic review. Gait Posture. 2021;89:139-60. 10.1016/j.gaitpost.2021.04.042</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gaitpost.2021.04.042</ArticleId><ArticleId IdType="pubmed">34284334</ArticleId></ArticleIdList></Reference><Reference><Citation>Polmann H, Domingos FL, Melo G, Stuginski-Barbosa J, Guerra ENdS, Porporatti AL, et al. Association between sleep bruxism and anxiety symptoms in adults: A systematic review. J Oral Rehabil. 2019;46:482-91. 10.1111/joor.12785</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joor.12785</ArticleId><ArticleId IdType="pubmed">30805947</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonnweber T, Sahanic S, Pizzini A, Luger A, Schwabl C, Sonnweber B, et al. Cardiopulmonary recovery after COVID-19: an observational prospective multicentre trial. Eur Respir J. 2021;57:04. 10.1183/13993003.03481-2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.03481-2020</ArticleId><ArticleId IdType="pmc">PMC7736754</ArticleId><ArticleId IdType="pubmed">33303539</ArticleId></ArticleIdList></Reference><Reference><Citation>Daher A, Balfanz P, Cornelissen C, Muller A, Bergs I, Marx N, et al. Follow up of patients with severe coronavirus disease 2019 (COVID-19): Pulmonary and extrapulmonary disease sequelae. Respir Med. 2020;174:106197. 10.1016/j.rmed.2020.106197</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2020.106197</ArticleId><ArticleId IdType="pmc">PMC7573668</ArticleId><ArticleId IdType="pubmed">33120193</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahmud R, Rahman MM, Rassel MA, Monayem FB, Sayeed S, Islam MS, et al. Post-COVID-19 syndrome among symptomatic COVID-19 patients: A prospective cohort study in a tertiary care center of Bangladesh. PLoS One. 2021;16:e0249644. 10.1371/journal.pone.0249644</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0249644</ArticleId><ArticleId IdType="pmc">PMC8031743</ArticleId><ArticleId IdType="pubmed">33831043</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellan M, Soddu D, Balbo PE, Baricich A, Zeppegno P, Avanzi GC, et al. Respiratory and Psychophysical Sequelae Among Patients With COVID-19 Four Months After Hospital Discharge. JAMA Netw Open. 2021;4:e2036142. 10.1001/jamanetworkopen.2020.36142</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2020.36142</ArticleId><ArticleId IdType="pmc">PMC7841464</ArticleId><ArticleId IdType="pubmed">33502487</ArticleId></ArticleIdList></Reference><Reference><Citation>Bliddal S, Banasik K, Pedersen OB, Nissen J, Cantwell L, Schwinn M, et al. Acute and persistent symptoms in non-hospitalized PCR-confirmed COVID-19 patients. Sci Rep. 2021;11:13153. 10.1038/s41598-021-92045-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-92045-x</ArticleId><ArticleId IdType="pmc">PMC8222239</ArticleId><ArticleId IdType="pubmed">34162913</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiesa-Estomba CM, Lechien JR, Radulesco T, Michel J, Sowerby LJ, Hopkins C, et al. Patterns of smell recovery in 751 patients affected by the COVID-19 outbreak. Eur J Neurol. 2020;27:2318-21. 10.1111/ene.14440</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14440</ArticleId><ArticleId IdType="pmc">PMC7405216</ArticleId><ArticleId IdType="pubmed">32677329</ArticleId></ArticleIdList></Reference><Reference><Citation>Cousyn L, Sellem B, Palich R, Bendetowicz D, Agher R, Delorme C, et al. Olfactory and gustatory dysfunctions in COVID-19 outpatients: A prospective cohort study. Infect Dis Now. 2021;51:440-4. 10.1016/j.idnow.2021.03.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.idnow.2021.03.004</ArticleId><ArticleId IdType="pmc">PMC7983360</ArticleId><ArticleId IdType="pubmed">33766735</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C, Guijarro C, Plaza-Canteli S, Hernandez-Barrera V, Torres-Macho J.Prevalence of Post-COVID-19 Cough One Year After SARS-CoV-2 Infection: A Multicenter Study. Lung. 2021;199:249-53. 10.1007/s00408-021-00450-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00408-021-00450-w</ArticleId><ArticleId IdType="pmc">PMC8124095</ArticleId><ArticleId IdType="pubmed">33993321</ArticleId></ArticleIdList></Reference><Reference><Citation>Froidure A, Mahsouli A, Liistro G, De Greef J, Belkhir L, Gerard L, et al. Integrative respiratory follow-up of severe COVID-19 reveals common functional and lung imaging sequelae. Respir Med. 2021;181:106383. 10.1016/j.rmed.2021.106383</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2021.106383</ArticleId><ArticleId IdType="pmc">PMC8019490</ArticleId><ArticleId IdType="pubmed">33839588</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerhards C, Thiaucourt M, Kittel M, Becker C, Ast V, Hetjens M, et al. Longitudinal assessment of anti-SARS-CoV-2 antibody dynamics and clinical features following convalescence from a COVID-19 infection. Int J Infect Dis. 2021;107:221-7. 10.1016/j.ijid.2021.04.080</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.04.080</ArticleId><ArticleId IdType="pmc">PMC8080496</ArticleId><ArticleId IdType="pubmed">33932604</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosn J, Piroth L, Epaulard O, Le Turnier P, Mentre F, Bachelet D, et al. Persistent COVID-19 symptoms are highly prevalent 6 months after hospitalization: results from a large prospective cohort. Clin Microbiol Infect. 2021;27:1041.e1-4. 10.1016/j.cmi.2021.03.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.03.012</ArticleId><ArticleId IdType="pmc">PMC8107834</ArticleId><ArticleId IdType="pubmed">34125067</ArticleId></ArticleIdList></Reference><Reference><Citation>Han X, Fan Y, Alwalid O, Li N, Jia X, Yuan M, et al. Six-month Follow-up Chest CT Findings after Severe COVID-19 Pneumonia. Radiology. 2021;299:E177-86. 10.1148/radiol.2021203153</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2021203153</ArticleId><ArticleId IdType="pmc">PMC7841877</ArticleId><ArticleId IdType="pubmed">33497317</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes E, Wist J, Masuda R, Lodge S, Nitschke P, Kimhofer T, et al. Incomplete Systemic Recovery and Metabolic Phenoreversion in Post-Acute-Phase Nonhospitalized COVID-19 Patients: Implications for Assessment of Post-Acute COVID-19 Syndrome. J Proteome Res. 2021;20:3315-29. 10.1021/acs.jproteome.1c00224</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jproteome.1c00224</ArticleId><ArticleId IdType="pubmed">34009992</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs LG, Gourna Paleoudis E, Lesky-Di Bari D, Nyirenda T, Friedman T, Gupta A, et al. Persistence of symptoms and quality of life at 35 days after hospitalization for COVID-19 infection. PLoS One. 2020;15:e0243882. 10.1371/journal.pone.0243882</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0243882</ArticleId><ArticleId IdType="pmc">PMC7732078</ArticleId><ArticleId IdType="pubmed">33306721</ArticleId></ArticleIdList></Reference><Reference><Citation>Leth S, Gunst JD, Mathiasen V, Hansen K, Sogaard O, Ostergaard L, et al. Persistent symptoms in patients recovering from COVID-19 in Denmark. Open Forum Infect Dis. 2021;8:b042. 10.1093/ofid/ofab042</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofab042</ArticleId><ArticleId IdType="pmc">PMC7928683</ArticleId><ArticleId IdType="pubmed">33875970</ArticleId></ArticleIdList></Reference><Reference><Citation>Otte MS, Bork ML, Zimmermann PH, Klussmann JP, Luers JC.Persisting olfactory dysfunction improves in patients 6 months after COVID-19 disease. Acta Otolaryngol. 2021;141:626-9. 10.1080/00016489.2021.1905178</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00016489.2021.1905178</ArticleId><ArticleId IdType="pubmed">33823752</ArticleId></ArticleIdList></Reference><Reference><Citation>Peghin M, Palese A, Venturini M, De Martino M, Gerussi V, Graziano E, et al. Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients. Clin Microbiol Infect. 2021;27:1507-13. 10.1016/j.cmi.2021.05.033</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.05.033</ArticleId><ArticleId IdType="pmc">PMC8180450</ArticleId><ArticleId IdType="pubmed">34111579</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, et al. Attributes and predictors of long COVID. Nat Med. 2021;27:626-31. 10.1038/s41591-021-01292-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaira LA, Hopkins C, Petrocelli M, Lechien JR, Chiesa-Estomba CM, Salzano G, et al. Smell and taste recovery in coronavirus disease 2019 patients: a 60-day objective and prospective study. J Laryngol Otol. 2020;134:703-9. 10.1017/S0022215120001826</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0022215120001826</ArticleId><ArticleId IdType="pmc">PMC7471571</ArticleId><ArticleId IdType="pubmed">32782030</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne JA, Sutton AJ, Ioannidis JP, Terrin N, Jones DR, Lau J, et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ. 2011;343:d4002. 10.1136/bmj.d4002</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.d4002</ArticleId><ArticleId IdType="pubmed">21784880</ArticleId></ArticleIdList></Reference><Reference><Citation>Gartlehner G, Affengruber L, Titscher V, Noel-Storr A, Dooley G, Ballarini N, et al. Single-reviewer abstract screening missed 13 percent of relevant studies: a crowd-based, randomized controlled trial. J Clin Epidemiol. 2020;121:20-8. 10.1016/j.jclinepi.2020.01.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2020.01.005</ArticleId><ArticleId IdType="pubmed">31972274</ArticleId></ArticleIdList></Reference><Reference><Citation>Buscemi N, Hartling L, Vandermeer B, Tjosvold L, Klassen TP.Single data extraction generated more errors than double data extraction in systematic reviews. J Clin Epidemiol. 2006;59:697-703. 10.1016/j.jclinepi.2005.11.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2005.11.010</ArticleId><ArticleId IdType="pubmed">16765272</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennis A, Wamil M, Alberts J, Oben J, Cuthbertson DJ, Wootton D, et al. Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study. BMJ Open. 2021;11:e048391.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8727683</ArticleId><ArticleId IdType="pubmed">33785495</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L, Zhao P, Tang D, Zhu T, Han R, Zhan C, et al. Cardiac Involvement in Patients Recovered From COVID-2019 Identified Using Magnetic Resonance Imaging. JACC Cardiovasc Imaging. 2020;13:2330-9. 10.1016/j.jcmg.2020.05.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2020.05.004</ArticleId><ArticleId IdType="pmc">PMC7214335</ArticleId><ArticleId IdType="pubmed">32763118</ArticleId></ArticleIdList></Reference><Reference><Citation>Joy G, Artico J, Kurdi H, Seraphim A, Lau C, Thornton GD, et al. Prospective Case-Control Study of Cardiovascular Abnormalities 6 Months Following Mild COVID-19 in Healthcare Workers. JACC Cardiovasc Imaging. 2021;14:2155-66. 10.1016/j.jcmg.2021.04.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2021.04.011</ArticleId><ArticleId IdType="pmc">PMC8105493</ArticleId><ArticleId IdType="pubmed">33975819</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrucci R, Dini M, Groppo E, Rosci C, Reitano MR, Bai F, et al. Long-lasting cognitive abnormalities after COVID-19. Brain Sci. 2021;11:1-11. 10.3390/brainsci11020235</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci11020235</ArticleId><ArticleId IdType="pmc">PMC7917789</ArticleId><ArticleId IdType="pubmed">33668456</ArticleId></ArticleIdList></Reference><Reference><Citation>Borsetto D, Hopkins C, Philips V, Obholzer R, Tirelli G, Polesel J, et al. Self-reported alteration of sense of smell or taste in patients with COVID-19: a systematic review and meta-analysis on 3563 patients. Rhinology. 2020;58:430-6. 10.4193/Rhin20.185</Citation><ArticleIdList><ArticleId IdType="doi">10.4193/Rhin20.185</ArticleId><ArticleId IdType="pubmed">32626853</ArticleId></ArticleIdList></Reference><Reference><Citation>Mihara M, Hashizume M, Yoshida H, Suzuki M, Shiina M.IL-6/IL-6 receptor system and its role in physiological and pathological conditions. Clin Sci (Lond). 2012;122:143-59. 10.1042/CS20110340</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/CS20110340</ArticleId><ArticleId IdType="pubmed">22029668</ArticleId></ArticleIdList></Reference><Reference><Citation>Sproston NR, Ashworth JJ.Role of C-reactive protein at sites of inflammation and infection. Front Immunol. 2018;9:754. 10.3389/fimmu.2018.00754</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.00754</ArticleId><ArticleId IdType="pmc">PMC5908901</ArticleId><ArticleId IdType="pubmed">29706967</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>